Funduscopic results after 4-year follow-up treatment with ranibizumab for age-related macular degeneration in a region of Spain

Background The study aims to survey longstanding funduscopic and functional outcomes of age-related macular degeneration (AMD) after ranibizumab treatment and verify the accuracy of a new method to compare the retinal thickness measured with different optical coherence tomography (OCT) tools.